Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.28B |
| 2 |
Microsoft
MSFT
|
+$593M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$572M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$435M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.72B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.83B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$803M |
| 4 |
Apple
AAPL
|
+$730M |
| 5 |
American Express
AXP
|
+$563M |
Sector Composition
| 1 | Technology | 21.38% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 9.34% |
| 4 | Communication Services | 8.4% |
| 5 | Healthcare | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4726
Scilex Holding
SCLX
$179M
| $157K | ﹤0.01% |
808
-269
| -25% | -$52.4K |
|
4727
Carter Bankshares
CARE
$447M
| $157K | ﹤0.01% |
10,624
-5,236
| -33% | -$77.4K |
|
|
PCN
4728
PIMCO Corporate & Income Strategy Fund
PCN
$892M
| $157K | ﹤0.01% |
+11,970
| New | +$157K |
|
|
PCM
4729
PCM Fund
PCM
$80.9M
| $157K | ﹤0.01% |
16,287
-3,886
| -19% | -$37.4K |
|
|
FSCO
4730
FS Credit Opportunities Corp
FSCO
$1.48B
| $157K | ﹤0.01% |
33,013
+3,414
| +12% | +$16.2K |
|
4731
Tiptree Inc
TIPT
$889M
| $157K | ﹤0.01% |
10,435
-30,081
| -74% | -$452K |
|
4732
Ooma
OOMA
$351M
| $157K | ﹤0.01% |
10,455
-56
| -0.5% | -$838 |
|
|
VCSA
4733
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $156K | ﹤0.01% |
11,514
+8,275
| +255% | +$112K |
|
4734
Rimini Street
RMNI
$425M
| $156K | ﹤0.01% |
32,536
-16,506
| -34% | -$79.1K |
|
4735
CytomX Therapeutics
CTMX
$328M
| $155K | ﹤0.01% |
90,242
-257,544
| -74% | -$443K |
|
4736
Humacyte
HUMA
$242M
| $155K | ﹤0.01% |
54,268
+22,901
| +73% | +$65.5K |
|
|
CCV
4737
DELISTED
Churchill Capital Corp V
CCV
| $155K | ﹤0.01% |
+15,224
| New | +$155K |
|
4738
Applied DNA Sciences
APDN
$3.59M
| $155K | ﹤0.01% |
8
-1
| -11% | -$19.3K |
|
|
PFN
4739
PIMCO Income Strategy Fund II
PFN
$716M
| $154K | ﹤0.01% |
21,427
-12,773
| -37% | -$92.1K |
|
4740
Latham Group
SWIM
$916M
| $154K | ﹤0.01% |
41,596
-26,404
| -39% | -$98K |
|
|
HEPA
4741
DELISTED
Hepion Pharmaceuticals
HEPA
| $154K | ﹤0.01% |
293
+138
| +89% | +$72.6K |
|
4742
Aquestive Therapeutics
AQST
$622M
| $154K | ﹤0.01% |
93,199
-23,073
| -20% | -$38.1K |
|
|
FFNW
4743
DELISTED
First Financial Northwest, Inc
FFNW
| $153K | ﹤0.01% |
13,498
-4,849
| -26% | -$55.1K |
|
4744
Antero Midstream
AM
$8.79B
| $153K | ﹤0.01% |
13,166
-12,040
| -48% | -$140K |
|
|
NGM
4745
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $152K | ﹤0.01% |
58,841
-7,582
| -11% | -$19.6K |
|
4746
Anixa Biosciences
ANIX
$113M
| $151K | ﹤0.01% |
47,258
-108,526
| -70% | -$347K |
|
4747
Snow Lake Resources
LITM
$32.5M
| $151K | ﹤0.01% |
5,057
+4,027
| +391% | +$120K |
|
|
DSM
4748
BNY Mellon Strategic Municipal Bond Fund
DSM
$294M
| $151K | ﹤0.01% |
+26,477
| New | +$151K |
|
4749
Relmada Therapeutics
RLMD
$55.4M
| $151K | ﹤0.01% |
61,302
-16,812
| -22% | -$41.4K |
|
4750
ProShares UltraShort Consumer Staples
SZK
$760K
| $150K | ﹤0.01% |
+10,427
| New | +$150K |
|